• Je něco špatně v tomto záznamu ?

Protective effects of osajin in ischemia-reperfusion of laboratory rat kidney

Bartošíková L., Nečas J., Suchý V., Janoštíková E., Bartošík T., Juřica J., Florian T., Klusáková J., Frydrych M.

. 2006 ; 61 (6) : 552-555.

Jazyk angličtina Země Německo

Perzistentní odkaz   https://www.medvik.cz/link/bmc07522670

Grantová podpora
NL7455 MZ0 CEP - Centrální evidence projektů

Digitální knihovna NLK
Plný text - Část
Zdroj

E-zdroje Online

NLK Freely Accessible Science Journals od 2003 do Před 1 rokem

The aim of this study was to analyze the antioxidative effect of osajin during prophylactic administration. The pathological model for in vivo experiment was the unilateral ischemia-reperfusion of kidney of the laboratory rat. The animals were randomly divided into five groups. Osajin was administrated orally in doses of 5, 10 and 20 mg/kg once a day to three premedicated groups. Placebo--0.5% solution of Avicel--was given to the fourth group and the fifth group was completely intact. The premedication lasted 15 days and subsequently the ischemia of the left kidney was incited in general anaesthesia for 60 min. The reperfusion lasted 10 min and it was finished by blood collection from the left ventricle and the reperfused kidney was recovered. Selected biochemical markers were assessed in blood: superoxide dismutase, glutathion peroxidase, total antioxidative capacity and malondialdehyde. The kidney tissue samples were used for histopathological examination. Laboratory and histopathological results confirmed supposed effects of osajine. The dependence between the effect and the applied dose of osajin was linear. The best biochemical results were reached after administration of osajin at the dose of 5 mg/kg. The best histopathological results were reached after administration of osajin at the dose of 10 mg/kg.

000      
00000naa 2200000 a 4500
001      
bmc07522670
003      
CZ-PrNML
005      
20130603101617.0
008      
090506s2006 gw e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Bartošíková, Lenka, $d 1968- $7 nlk20020124783
245    10
$a Protective effects of osajin in ischemia-reperfusion of laboratory rat kidney / $c Bartošíková L., Nečas J., Suchý V., Janoštíková E., Bartošík T., Juřica J., Florian T., Klusáková J., Frydrych M.
314    __
$a Department of Human Pharmacology and Toxicology, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Brno, Czech Republic. bartosikoval@vfu.cz
520    9_
$a The aim of this study was to analyze the antioxidative effect of osajin during prophylactic administration. The pathological model for in vivo experiment was the unilateral ischemia-reperfusion of kidney of the laboratory rat. The animals were randomly divided into five groups. Osajin was administrated orally in doses of 5, 10 and 20 mg/kg once a day to three premedicated groups. Placebo--0.5% solution of Avicel--was given to the fourth group and the fifth group was completely intact. The premedication lasted 15 days and subsequently the ischemia of the left kidney was incited in general anaesthesia for 60 min. The reperfusion lasted 10 min and it was finished by blood collection from the left ventricle and the reperfused kidney was recovered. Selected biochemical markers were assessed in blood: superoxide dismutase, glutathion peroxidase, total antioxidative capacity and malondialdehyde. The kidney tissue samples were used for histopathological examination. Laboratory and histopathological results confirmed supposed effects of osajine. The dependence between the effect and the applied dose of osajin was linear. The best biochemical results were reached after administration of osajin at the dose of 5 mg/kg. The best histopathological results were reached after administration of osajin at the dose of 10 mg/kg.
650    _2
$a financování organizované $7 D005381
650    _2
$a zvířata $7 D000818
650    _2
$a antioxidancia $x terapeutické užití $7 D000975
650    _2
$a benzopyrany $x terapeutické užití $7 D001578
650    _2
$a glutathionperoxidasa $x metabolismus $7 D005979
650    _2
$a isoflavony $x terapeutické užití $7 D007529
650    _2
$a ledviny $x enzymologie $x patologie $7 D007668
650    _2
$a nemoci ledvin $x enzymologie $x patologie $x prevence a kontrola $7 D007674
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a malondialdehyd $x metabolismus $7 D008315
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
650    _2
$a reperfuzní poškození $x enzymologie $x patologie $x prevence a kontrola $7 D015427
650    _2
$a superoxiddismutasa $x metabolismus $7 D013482
700    1_
$a Nečas, Jiří, $d 1954- $7 nlk19990073608
700    1_
$a Suchý, Václav, $d 1936- $7 jn20000402312
700    1_
$a Janoštíková, Eva $7 xx0104722
700    1_
$a Bartošík, Tomáš $7 xx0147653
700    1_
$a Juřica, Jan $7 xx0085543
700    1_
$a Florian, Tomáš $7 xx0104725
700    1_
$a Klusáková, Jarmila, $d 1956- $7 mzk2005269589
700    1_
$a Frydrych, Marek $7 xx0104730
773    0_
$w MED00003807 $t Die Pharmazie $g Roč. 61, č. 6 (2006), s. 552-555 $x 0031-7144
910    __
$a ABA008 $b x $y 9
990    __
$a 20090310084605 $b ABA008
991    __
$a 20130603101951 $b ABA008
999    __
$a ok $b bmc $g 650762 $s 503925
BAS    __
$a 3
BMC    __
$a 2006 $b 61 $c 6 $d 552-555 $i 0031-7144 $m Die Pharmazie $x MED00003807
GRA    __
$a NL7455 $p MZ0
LZP    __
$a 2009-B3/ipme

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...